Filing Details
- Accession Number:
- 0001179110-20-009277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-24 18:38:18
- Reporting Period:
- 2020-08-20
- Accepted Time:
- 2020-08-24 18:38:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1668718 | D Philip Worboys | C/O Theravance Biopharma Us, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Svp, Research & Transl Science | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2020-08-20 | 17,103 | $18.00 | 333,252 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2020-08-20 | 4,804 | $18.22 | 328,448 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | F | Direct |